Advanced CML: therapeutic options for patients in accelerated and blast phases
about
Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression dataCharacterization of chronic myeloid leukemia stem cells.Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.Clinical and technical phosphoproteomic research.Technical phosphoproteomic and bioinformatic tools useful in cancer research.Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.
P2860
Advanced CML: therapeutic options for patients in accelerated and blast phases
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Advanced CML: therapeutic options for patients in accelerated and blast phases
@ast
Advanced CML: therapeutic options for patients in accelerated and blast phases
@en
Advanced CML: therapeutic options for patients in accelerated and blast phases
@nl
type
label
Advanced CML: therapeutic options for patients in accelerated and blast phases
@ast
Advanced CML: therapeutic options for patients in accelerated and blast phases
@en
Advanced CML: therapeutic options for patients in accelerated and blast phases
@nl
prefLabel
Advanced CML: therapeutic options for patients in accelerated and blast phases
@ast
Advanced CML: therapeutic options for patients in accelerated and blast phases
@en
Advanced CML: therapeutic options for patients in accelerated and blast phases
@nl
P1476
Advanced CML: therapeutic options for patients in accelerated and blast phases
@en
P2093
Neil P Shah
P304
P407
P478
P577
2008-03-01T00:00:00Z